Changes in AMPK activity induces cellular senescence in human dental follicle cells

Exp Gerontol. 2023 Feb:172:112071. doi: 10.1016/j.exger.2022.112071. Epub 2022 Dec 21.

Abstract

Dental Follicle Cells (DFCs) are somatic stem cells with a limited lifespan, but little is known about a possible mechanism of cellular senescence. Previous studies have shown that cellular senescence is associated with increased demand of glycolsis or the "glycolytic metabotype", which can be induced by activation of 5' adenosine monophosphate-activated protein kinase (AMPK), and decreased autophagy. This study examined the role of AMPK in inducing senescence in DFCs. During the induction of cellular senescence, AMPK activity was impaired, suggesting a negative impact on senescence induction. In line with this assumption, cellular senescence was induced upon inhibition of AMPK with a specific siRNA. In addition, after this inhibition, autophagy was also inhibited. Moreover, specific inhibition of autophagy promoted cellular senescence. However, inducers of AMPK such as metformin or AICAR surprisingly increased senescence in DFCs. Interestingly, autophagy was impaired after long-term induction of AMPK with AICAR and metformin. Moreover, activation of AMPK induces the consumption of glucose but decreases NAD/NADH ratio in DFCs that suggest not only "glycolytic metabotype" of DFCs but also Mitochondrial Dysfunction Associated Senescence (MiDAS). Both changes are highly associated with the induction of cellular senescence. Hence, both AMPK activation and inhibition promote the induction of cellular senecence of DFCs.

Keywords: AMP-kinase; Autophagy; Cellular senescence; Dental follicle cells; Metformin.

MeSH terms

  • AMP-Activated Protein Kinases* / metabolism
  • Autophagy
  • Cellular Senescence
  • Dental Sac / metabolism
  • Humans
  • Metformin* / pharmacology
  • Phosphorylation

Substances

  • AMP-Activated Protein Kinases
  • Metformin